Compare MTA & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MTA | BVS |
|---|---|---|
| Founded | 1983 | 2011 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 766.4M | 617.1M |
| IPO Year | 2017 | 2016 |
| Metric | MTA | BVS |
|---|---|---|
| Price | $7.51 | $10.64 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $9.00 | ★ $14.00 |
| AVG Volume (30 Days) | 356.7K | ★ 435.5K |
| Earning Date | 05-15-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 163.46 |
| EPS | N/A | ★ 0.04 |
| Revenue | N/A | ★ $568,087,000.00 |
| Revenue This Year | $81.63 | $7.52 |
| Revenue Next Year | $62.44 | $7.06 |
| P/E Ratio | ★ N/A | $265.75 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.83 | $5.81 |
| 52 Week High | $9.25 | $11.25 |
| Indicator | MTA | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 58.91 | 60.36 |
| Support Level | $7.08 | $8.27 |
| Resistance Level | $7.73 | $11.00 |
| Average True Range (ATR) | 0.33 | 0.56 |
| MACD | 0.11 | -0.01 |
| Stochastic Oscillator | 80.43 | 62.64 |
Metalla Royalty & Streaming Ltd is a precious metals royalty and streaming company, which engages in the acquisition and management of precious metal royalties, streams, and similar production-based interests. It's a pure-play gold and silver streaming and royalty company. It generates revenue from royalties, streams, and other interests.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.